Le ultime news oncologiche dall'Italia e dal mondo
Science blog Specialist prostate cancer MRI scans recommended on NHSA type of specialist MRI scan has been recommended as one of the first tests for diagnosing people with suspected prostate cancer. Studies have found that using mpMRI could help 1 in 4[…]
Ispezionate 224 mense presenti negli istituti scolastici del territorio nazionale, delle quali 81 hanno evidenziato irregolaritàData di pubblicazione: 14/12/2018
Read more...
Science blog This week, the National Institute for Health and Care Excellence (NICE) finished its review of a thyroid cancer drug called vandetanib (Caprelsa). This is business as usual for NICE, which decides whether the NHS should pay for new[…]
On line anche la consultazione per i proprietari degli animaliData di pubblicazione: 14/12/2018
Read more...
Language EnglishDecember 13, 2018lidia.schapiraIn this month’s From the Editor’s Desk, Dr. Schapira discusses the role of tracking and reporting side effects in high-quality care, including advances in patient-reported outcomes or PROs.
Prevalence has increased rapidly in most countries across all population groups
Read more...
Language SpanishDecember 11, 2018Enrique.SotoSi hay una catástrofe natural en su área, puede ser difícil obtener la atención para el cáncer que usted necesita. Aprenda lo que puede hacer antes, durante y después de una situación de emergencia para asegurarse de[…]
Read more...
A clinical trial showed that ibrutinib plus rituximab is superior to standard treatment for patients age 70 and younger with untreated chronic lymphocytic leukemia (CLL). Findings were announced at the American Society of Hematology annual meeting.
Read more...Senator John McCain, a long-time supporter of cancer research, passed away on August 25.
Read more...Results from a recent study show that some differences exist in NSCLC gene expression from African Americans and European Americans, which could be leveraged to improve patient outcome in both populations.
Read more...Researchers have identified mutations that may help distinguish which laryngeal cancer patients could benefit from therapy, since the disease is notoriously resistant to chemotherapeutic treatments.
Read more...
